 Anna Peljto
Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 11 | 2025 | 654 | 1.830 |
Why?
| | Mucin-5B | 9 | 2025 | 224 | 1.390 |
Why?
| | Lung Diseases, Interstitial | 5 | 2024 | 636 | 0.700 |
Why?
| | Polymorphism, Genetic | 3 | 2016 | 659 | 0.670 |
Why?
| | Genetic Predisposition to Disease | 6 | 2023 | 2412 | 0.600 |
Why?
| | Scleroderma, Systemic | 2 | 2013 | 122 | 0.470 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 455 | 0.370 |
Why?
| | Pulmonary Fibrosis | 2 | 2016 | 399 | 0.330 |
Why?
| | Epilepsy | 1 | 2014 | 331 | 0.320 |
Why?
| | Genome-Wide Association Study | 3 | 2023 | 1428 | 0.260 |
Why?
| | Registries | 1 | 2014 | 2015 | 0.240 |
Why?
| | Genotype | 6 | 2025 | 1914 | 0.230 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2022 | 2184 | 0.220 |
Why?
| | Arthritis, Rheumatoid | 2 | 2024 | 1167 | 0.210 |
Why?
| | Genetic Association Studies | 3 | 2015 | 375 | 0.190 |
Why?
| | Whole Genome Sequencing | 1 | 2023 | 153 | 0.190 |
Why?
| | Exome | 1 | 2023 | 230 | 0.190 |
Why?
| | Lung | 7 | 2025 | 4062 | 0.180 |
Why?
| | Signal Transduction | 1 | 2015 | 5076 | 0.180 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2022 | 97 | 0.180 |
Why?
| | Risk | 2 | 2014 | 908 | 0.170 |
Why?
| | Aged | 8 | 2025 | 23794 | 0.150 |
Why?
| | Tomography, X-Ray Computed | 4 | 2025 | 2667 | 0.150 |
Why?
| | Genetic Variation | 2 | 2015 | 985 | 0.130 |
Why?
| | Middle Aged | 8 | 2025 | 33228 | 0.130 |
Why?
| | Phenotype | 4 | 2025 | 3189 | 0.130 |
Why?
| | Republic of Korea | 1 | 2015 | 36 | 0.120 |
Why?
| | Humans | 18 | 2025 | 136765 | 0.120 |
Why?
| | Promoter Regions, Genetic | 3 | 2016 | 1249 | 0.110 |
Why?
| | Mexico | 1 | 2015 | 225 | 0.110 |
Why?
| | Minnesota | 1 | 2014 | 162 | 0.100 |
Why?
| | Carbon Monoxide | 1 | 2012 | 80 | 0.100 |
Why?
| | Incidence | 2 | 2023 | 2792 | 0.100 |
Why?
| | Male | 9 | 2025 | 67311 | 0.090 |
Why?
| | Vital Capacity | 1 | 2012 | 311 | 0.090 |
Why?
| | Genetic Loci | 1 | 2013 | 288 | 0.090 |
Why?
| | Gene Frequency | 3 | 2022 | 520 | 0.090 |
Why?
| | Female | 9 | 2025 | 72795 | 0.090 |
Why?
| | Cohort Studies | 3 | 2023 | 5701 | 0.090 |
Why?
| | Case-Control Studies | 3 | 2013 | 3539 | 0.090 |
Why?
| | Survival Analysis | 1 | 2013 | 1321 | 0.080 |
Why?
| | Risk Factors | 4 | 2023 | 10325 | 0.080 |
Why?
| | Logistic Models | 1 | 2015 | 2067 | 0.080 |
Why?
| | Disease | 1 | 2009 | 98 | 0.080 |
Why?
| | Chromosome Mapping | 1 | 2009 | 523 | 0.070 |
Why?
| | Long QT Syndrome | 1 | 2009 | 70 | 0.070 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 428 | 0.060 |
Why?
| | Genetic Markers | 2 | 2022 | 344 | 0.060 |
Why?
| | Smoking | 2 | 2024 | 1620 | 0.060 |
Why?
| | Telomere Shortening | 1 | 2024 | 20 | 0.050 |
Why?
| | Adult | 3 | 2022 | 37631 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2014 | 6032 | 0.050 |
Why?
| | Respiratory Mucosa | 1 | 2025 | 322 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2025 | 405 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2014 | 7585 | 0.050 |
Why?
| | Retrospective Studies | 2 | 2023 | 15504 | 0.040 |
Why?
| | Dyspnea | 1 | 2023 | 254 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2022 | 240 | 0.040 |
Why?
| | Telomere | 1 | 2024 | 280 | 0.040 |
Why?
| | Infant | 1 | 2014 | 9395 | 0.040 |
Why?
| | Fibroblasts | 1 | 2025 | 993 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 551 | 0.040 |
Why?
| | Child, Preschool | 1 | 2014 | 10997 | 0.040 |
Why?
| | Young Adult | 1 | 2014 | 13127 | 0.030 |
Why?
| | Mutation | 2 | 2022 | 3946 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2710 | 0.030 |
Why?
| | Heterozygote | 1 | 2016 | 293 | 0.030 |
Why?
| | Adolescent | 1 | 2014 | 21382 | 0.030 |
Why?
| | Child | 1 | 2014 | 21819 | 0.030 |
Why?
| | Chromosomes, Human | 1 | 2013 | 44 | 0.030 |
Why?
| | Alleles | 1 | 2016 | 890 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 809 | 0.020 |
Why?
| | Sampling Studies | 1 | 2009 | 99 | 0.020 |
Why?
| | Death, Sudden | 1 | 2009 | 24 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 7572 | 0.020 |
Why?
| | Genes | 1 | 2009 | 230 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2022 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2009 | 268 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1500 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2009 | 333 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2009 | 575 | 0.020 |
Why?
| | Family | 1 | 2009 | 665 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1935 | 0.010 |
Why?
| | Animals | 1 | 2025 | 36847 | 0.010 |
Why?
|
|
Peljto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|